DexCom, Inc. (DXCM)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 332.16 |
| Open | 327.06 |
| Bid | 307.01 x 800 |
| Ask | 306.01 x 800 |
| Day's range | 307.00 - 328.17 |
| 52-week range | 302.61 - 659.45 |
| Volume | |
| Avg. volume | 800,803 |
| Market cap | 29.899B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | 58.18 |
| EPS (TTM) | 5.30 |
| Earnings date | 27 Apr 2022 - 02 May 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 546.94 |
- Simply Wall St.
Are DexCom, Inc. (NASDAQ:DXCM) Investors Paying Above The Intrinsic Value?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of DexCom, Inc...
- Motley Fool
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
Let's look at two top stocks that have performed worse than the broader market this year: DexCom (NASDAQ: DXCM) and Microsoft (NASDAQ: MSFT). Shares of medical devices specialist DexCom have dropped by 39% year to date. DexCom's own G6 CGM system continues to be highly successful.
- Business Wire
Dexcom Announces Upcoming Conference Presentations
SAN DIEGO, May 10, 2022--DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences:
© 2022 Yahoo. All rights reserved.
